• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Small Innovators & Niche CROs

    Focus on Science

    Rapid and Data Rich Chromatographic Method Development

    Preparing Your Post Pandemic Talent Strategy

    How Modern Near-Infrared Came to Be
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ

    Ascendia Pharmaceuticals Poised for Expansion

    Bora Pharmaceuticals Adds Roller Compaction Capabilities

    Merck KGaA Selects PRA’s Remote Patient Monitoring Platform

    AGC Biologics Appoints Jun Takami GM of Chiba Site
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Ascendia Pharmaceuticals Poised for Expansion

    Bora Pharmaceuticals Adds Roller Compaction Capabilities

    Alkermes, Merck Enter Clinical Trial and Supply Agreement

    Sterling Pharma Solutions Acquires ADC Biotechnology

    Moderna, Catalent Enter Long-Term Strategic Vax Pact
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Cryoport Acquires Critical Transport Solutions Australia

    PharmParts – This Makes Sense!

    Securing Your API Supply Chain: Three Keys to Success

    Enteris BioPharma: Custom Solutions – From Bench to Market

    The Benefits of Outsourcing Cold Storage
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ

    Ascendia Pharmaceuticals Poised for Expansion

    Merck KGaA Selects PRA’s Remote Patient Monitoring Platform

    Agilex Biolabs Acquires TetraQ for APAC Expansion Plans

    Alkermes, Merck Enter Clinical Trial and Supply Agreement
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    What Will Change at FDA for 2021?

    RBQM Comes of Age: COVID as a Catalyst for Change

    Post-Pandemic Regulations

    Enteris BioPharma: Custom Solutions – From Bench to Market

    Metrics Contract Services Completes Russian Regulatory Inspection
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Reed-Lane

    Quotient Sciences

    PCI Pharma Services

    Emergent BioSolutions

    Syngene
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Baxter BioPharma Solutions

    Aphena Pharma Solutions

    Quotient Sciences

    Adare Pharma Solutions

    Alcami
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Anti-Counterfeiting in the Pharmaceutical Industry: An Evolution

    Keeping up with counterfeitors in the pharmaceutical industry is no easy task, but patients’ lives depend on it.

    Anti-Counterfeiting in the Pharmaceutical Industry: An Evolution
    Related CONTENT
    • Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
    • AGC Biologics Appoints Jun Takami GM of Chiba Site
    • Legacy Pharma Solutions Appoints President
    • What Will Change at FDA for 2021?
    • The Ever-Evolving World of Combination Products
    Ben Locwin, Healthcare Science Advisors10.04.19
    Ever since there have been products, there have been counterfeit products distracting the consumer from the originator. There is a small philosophical difference between an originator product and a counterfeit—and that difference mostly centers around the idea of intellectual property (IP). IP attorneys spend long days justifying the differences, or lack thereof, between an originator and a copy. Trillions of dollars are made on knock-off products, and while some are of decent quality, others endeavor to convince consumers that they’re equivalent to the original product and (woefully) are not by a long shot. Oftentimes this discrepancy will manifest in a defective product and consumer frustration, but in the pharmaceutical market, counterfeits can lead to serious adverse events (SAEs) and even death.

    In pharmaceuticals, counterfeiting not only impacts IP of the originator molecule, but it undermines the safety of the public. Because unlike toys or gadgets, drug therapies go through a substantial demonstration of efficacy in clinical trials, so to intentionally develop inert, or hazardous, copies undermines the intent of the final product. This is where the ethical problems enter in the pharmaceutical counterfeiting market. Make no mistake: There is a tremendous incentive to counterfeit pharmaceutical products, as it is currently a scheme worth over $75 billion annually.1

    Techniques for anti-counterfeiting
    Branded labels and logos exist to signal to consumers that what they have is the original product. Of course, the counterfeitors then need to duplicate each of these product-specific idiosyncracies.

    There are many examples of anti-counterfeiting technology in pharmaceuticals that have been foiled: Manufacturer brand debossing on tablets can be copied; packages duplicated; tablet and capsule morphologies replicated; and containers cloned, or sourced from the same closure vendors. Those individuals most likely to be fooled by counterfeiting are first-time users of a drug therapy, because they have no mental baseline as a comparator. There are also a lot of first-time users of drug products. Think of the number of patients multiplied by the permutations of the number of marketed drug products.

    It was only a couple decades ago that holograms on stickers and logos were the 21st century approach to anti-counterfeiting. These are now easily duplicated by counterfeitors. Drug forms that come in novel delivery devices such as auto-injector pens, transdermal patches, etc., offer some inherent resistance to counterfeiting. But first-time users wouldn’t know what to expect.

    Now drugs that offer cutting-edge patient data tracking will provide some anti-counterfeiting comfort for the time being, until patients begin to refuse drug treatments that track compliance. Serialization allows for tracking and tracing to a certain degree across the supply chain and ensures greater chain of custody for the manufacturer, and as more pharmacies become a part of the serialization effort, the system gets more robust. But it does not demonstrate to patients that their prescription hasn’t been counterfeited.

    Special consideration for regulators
    This is a serious problem for the pharmaceutical industry, as it is for the technology sector, art, music, textiles, and virtually every other extant industry. Counterfeitors in the pharmaceutical sector, however, risk patients’ lives. There is a deep latent risk as well, and that comes in the form of post-marketing surveillance for safety reports. Knowing which reported adverse events (AEs) for a particular drug are from actual marketed drug or a counterfeit replacement is virtually impossible. Therefore knowing which post-marketing safety signals are false positives, which is already a difficult task, becomes more difficult when patients report adverse events and may have been taking a counterfeited prescription. It is therefore incumbent upon us as ambassadors for this industry to continue to seek methods to make counterfeiting more and more difficult. All patients who take a prescription and expect a certain beneficial effect, and at the same time a particular margin of safety, deserve the best products we can produce. CP

    References and Further Reading
    1. Moran, B. “Cracking Down on Counterfeit Drugs.” http://www.pbs.org/wgbh/nova/next/body/uncovering-counterfeit-medicines/
    2. Davison, M. (2011). Pharmaceutical anti-counterfeiting: Combating the real danger from fake drugs. Hoboken, NJ: John Wiley & Sons, Inc.

    Ben Locwin

    Dr. Ben Locwin, PhD, MBA, MS is president of Healthcare Science Advisors and an author of a wide variety of scientific articles for books and magazines, as well as an acclaimed speaker. He can be reached at ben.locwin@healthcarescienceadvisors.com.
    Related Searches
    • intellectual property
    • tablets
    • events
    • it
    Suggested For You
    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
    AGC Biologics Appoints Jun Takami GM of Chiba Site AGC Biologics Appoints Jun Takami GM of Chiba Site
    Legacy Pharma Solutions Appoints President Legacy Pharma Solutions Appoints President
    What Will Change at FDA for 2021? What Will Change at FDA for 2021?
    The Ever-Evolving World of Combination Products The Ever-Evolving World of Combination Products
    Cold-Chain Handling Is Not Just a COVID Vaccine Challenge Cold-Chain Handling Is Not Just a COVID Vaccine Challenge
    Fast Track Automation in Pharmaceutical Manufacturing Fast Track Automation in Pharmaceutical Manufacturing
    Regulatory Practices in a Post-Pandemic World Regulatory Practices in a Post-Pandemic World
    Alcami Names Patrick D. Walsh as Chairman and CEO Alcami Names Patrick D. Walsh as Chairman and CEO
    Romaco Acquires STE Tecpharm Romaco Acquires STE Tecpharm
    Gilead, Novo Nordisk Expand NASH Alliance Gilead, Novo Nordisk Expand NASH Alliance
    Alcami Appoints Patrick D. Walsh as Chairman and Chief Executive Officer Alcami Appoints Patrick D. Walsh as Chairman and Chief Executive Officer
    Maravai Expands CDMO Capabilities Through TriLink Biotechnologies Maravai Expands CDMO Capabilities Through TriLink Biotechnologies
    Data Management Trends Data Management Trends
    Phlow Corp. and USP Form Alliance Phlow Corp. and USP Form Alliance

    Related Columns

    • Clinical Trials
      Synthetic Control Arms

      Synthetic Control Arms

      In clinical trials, they don’t always capture the most important dimensions
      Ben Locwin 03.06.19

    • Clinical Trials | Process Development

      China Vaults to the Top of U.S. Biomanufacturers’ Off-Shoring Prospects

      A look at top destinations for future offshoring
      Eric S. Langer, BioPlan Associates 06.02.16

    • Clinical Trials

      Are More CRO Transactions Near?

      When will we see additional transactions involving the largest CROs?
      Chad Moore, Leerink Partners LLC 06.02.16


    • Biosimilars | Clinical Trials | Drug Discovery | Process Development

      Like the Temperature, It Feels Like Deal Activity is Heating Up

      A summary of 2016 transactions so far
      Chad Moore, Leerink Partners LLC 05.05.16

    • Analytical Services | Clinical Trials | Laboratory Testing | Supply Chain

      Analytical Instruments are On-Board with Outsourcing

      Newer process instruments are finally being designed with mobility in mind
      Emil W. Ciurczak, DoraMaxx Consulting 01.28.16

    • Biosimilars | Clinical Trials

      Outsourced Pharma Services: 2015 Review & 2016 Outlook

      ...
      Chad Moore, Leerink Partners 01.28.16


    • APIs | Biosimilars | Clinical Trials | Process Development | Vials

      2015 in Review: 6 Key Trends Affecting CMOs

      A look at major CMO trends ranging from budgets to growth opportunities
      Eric S. Langer, BioPlan Associates 11.17.15

    • Clinical Trials | Drug Development

      Recap of Notable Recent CRO Transactions

      Conditions are expected to remain favorable for M&A and capital markets activity in the pharmaceutical service and IT sector
      Chad Moore 10.07.15

    • Clinical Trials | Process Development

      Globalization Hits Biopharma Contract Manufacturing

      CMOs no longer need to be local, and some countries are set to benefit
      Eric S. Langer, BioPlan Associates 10.07.15


    • Clinical Trials

      Clinical Trial Participants: Why So Elusive?

      Looking at how some companies are improving clinical trial efficiency and speed to solve the clinical trial participant conundrum
      Chad Moore, Robert W. Baird & Co. Inc. 09.11.15

    • Clinical Trials | Drug Development

      Medical Affairs: The Next Wave of Outsourcing?

      Outsourcing of medical affairs is on the rise, creating opportunities for third-party providers
      Chad Moore, Robert W. Baird & Co. Inc. 07.14.15

    • Analytical Services | APIs | Bioanalytical Services | Biosimilars | Chemistry | Clinical Trials | Excipients | GMPs/GCPs | Laboratory Testing | Microbiology | QA/QC | R&D | Regulatory Affairs | Supply Chain | Toxicology | Validation

      Inventas vitam iuvat excoluisse per artes (Let us improve life through science and art)

      But Qui bono? (Who benefits?)
      Emil W. Ciurczak, DoraMaxx Consulting 07.14.15


    • Clinical Trials

      Why Do Americans Pay More for Cancer Treatments?

      The ever-increasing cost of cancer treatments globally is a constant cause for discussion and price negotiation between Pharma companies and health care providers
      Adele Graham-King, Contributing Editor 05.06.15

    • Clinical Trials | Drug Development

      M&A Activity Heats Up

      Last year was hot, but 2015 looks to be hotter.
      Chad Moore, Robert W. Baird & Co. Inc. 01.29.15

    • Capsules | Cleaning Validation | Clinical Trials | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Lyophilization | Process Development | R&D | Serialization | Supply Chain | Validation

      Sometimes, Even a Good Workman Can Blame His Tools

      A new generation of equipment will help generate products with less cost and effort, while being made more efficiently.
      Emil W. Ciurczak, DoraMaxx Consulting 01.29.15

    Trending
    • Sterling Pharma Solutions Acquires ADC Biotechnology
    • Sanofi To Build New $700M Flu Vaccine Facility In Canada
    • Alkermes, Merck Enter Clinical Trial And Supply Agreement
    • Ascendia Pharmaceuticals Poised For Expansion
    • Frontage Expands Capabilities At Its Clinical Site In Secaucus, NJ
    Breaking News
    • Bora Pharmaceuticals Adds Roller Compaction Capabilities
    • Ascendia Pharmaceuticals Poised for Expansion
    • Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
    • Merck KGaA Selects PRA’s Remote Patient Monitoring Platform
    • AGC Biologics Appoints Jun Takami GM of Chiba Site
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Small Innovators & Niche CROs
    • Focus on Science
    • Rapid and Data Rich Chromatographic Method Development
    • Preparing Your Post Pandemic Talent Strategy
    • How Modern Near-Infrared Came to Be
    • Securing Your API Supply Chain: Three Keys to Success
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Kyowa Hakko Launches Heat-Treated Probiotic Strain for Eye Health
    CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status
    Nutritional Complex Evidenced to Reduce Preterm Birth
    Coatings World

    Latest Breaking News From Coatings World

    Barentz Expands Canadian CASE Team
    Shepherd Color Company Opens Sales Office in China
    Chromaflo Technologies Awarded Gold Status CSR Rating by EcoVadis in EMEA
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    CMS Establishes New Payment for Pelvalon’s Eclipse System
    Varian, Google Cloud Partner to Bring Convenience to Cancer Therapy
    Resonetics Leases New Manufacturing Space in Costa Rica
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
    Ascendia Pharmaceuticals Poised for Expansion
    Bora Pharmaceuticals Adds Roller Compaction Capabilities
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Revlon Unveils New Fragrances Featuring Megan Thee Stallion & Sofia Carson
    Henkel Management Board Welcomes Wolfgang König
    Mielle Organics Gets a Major Investment
    Happi

    Latest Breaking News From Happi

    Nature’s Beauty Debuts Vegan Natural Body Care at Walgreens
    Estée Lauder Expands 'Beautiful' Fagrance Collection
    Mushrooms Are Key Ingredients in Beauty & Wellness
    Ink World

    Latest Breaking News From Ink World

    SE-DA Invests in Kornit Presto S
    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    Iron Oxide Pigments Market to Register 4.7% CAGR from 2021 to 2028: GVR
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Dantex elevates Joseph Sanchez to digital business development manager
    Mactac's Kevin Clunie joins TLMI panel
    MacDermid announces two new global sales roles
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Precision Textiles Offers Biodegradable Medical Fabric
    Northshore Launches Megamax Briefs in New Colors
    Essity Acquires Distribution Rights to Sorbact in Australia and New Zealand
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    New Biosealant Could Stabilize Cartilage, Boost Healing After Injury
    Google Executive Joins SeaSpine's Board of Directors
    HSS and LimaCorporate Open Provider-Based 3D Design and Printing Facility
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Tive Multi-sensor Tracker Solo 5G Relies on Sensirion SHT33
    VTT in 2020: Successful Year Despite Globally Challenging Times
    Lux Research: 3D Printing Market to Reach $51 Billion in 2030

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login